Advertisement






Click here for more guidelines.
CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 2006; 48:1242-1249, doi:10.1016/j.jacc.2006.04.093 (Published online 25 August 2006).
© 2006 by the American College of Cardiology Foundation
This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kojodjojo, P.
Right arrow Articles by Peters, N. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kojodjojo, P.
Right arrow Articles by Peters, N. S.

The Effects of Carbenoxolone on Human Myocardial Conduction

A Tool to Investigate the Role of Gap Junctional Uncoupling in Human Arrhythmogenesis

Pipin Kojodjojo, MRCP, Prapa Kanagaratnam, PhD, MRCP*, Oliver R. Segal, MRCP, Wajid Hussain, MRCP and Nicholas S. Peters, MD, FRCP

St. Mary’s Hospital, Imperial College, London, United Kingdom.


Figure 1
View larger version (94K):

[in a new window]
 
Figure 1 Three-dimensional isochronal maps of the right atrium and ventricle from Patient #4 during sinus rhythm. The top left and right images show right atrial activation (right lateral projection) before and after administration of carbenoxolone, respectively. Atrial activation initiates in the region of the sinus node (red) and propagates in a craniocaudal direction with broad, fairly uniform wavefronts. The area of latest activation is shown in blue. The bottom left and right images show earliest right ventricular activation initiating from multiple sites of breakthrough around the apex (red), activating the ventricular mass with broad wavefronts and latest activation being seen around the tricuspid annulus (blue). A subjective crowding of isochrones can be seen after administration of carbenoxolone, in keeping with the slowing of conduction.

 

Figure 2
View larger version (44K):

[in a new window]
 
Figure 2 Schematic representation of a triad of 3 endocardial points, marked as O, A, and B. v represents wavefront propagation velocity.

 

Figure 3
View larger version (13K):

[in a new window]
 
Figure 3 Effects of carbenoxolone (CARB) on myocardial wavefront propagation velocities (WPVs).

 

Figure 4
View larger version (60K):

[in a new window]
 
Figure 4 Greater degree of atrial and ventricular conduction slowing in patients with a history of ischemic heart disease (IHD). WPV = wavefront propagation velocity.

 

Figure 5
View larger version (38K):

[in a new window]
 
Figure 5 Effects of carbenoxolone on cardiac refractoriness at 600 ms. AERP = absolute effective refractory period; DCS = distal coronary sinus; HRA = high right atrium; RVA = right ventricular apex; RVOT = right ventricular outflow tract.

 




 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement